BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33727557)

  • 1. dCas9 regulator to neutralize competition in CRISPRi circuits.
    Huang HH; Bellato M; Qian Y; Cárdenas P; Pasotti L; Magni P; Del Vecchio D
    Nat Commun; 2021 Mar; 12(1):1692. PubMed ID: 33727557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Levels of sgRNA as a Major Factor Affecting CRISPRi Knockdown Efficiency in K562 Cells].
    Wang Y; Xie Y; Dong ZC; Jiang XJ; Gong P; Lu J; Wan F
    Mol Biol (Mosk); 2021; 55(1):86-95. PubMed ID: 33566028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated Expression of sgRNAs Tunes CRISPRi in E. coli.
    Fontana J; Dong C; Ham JY; Zalatan JG; Carothers JM
    Biotechnol J; 2018 Sep; 13(9):e1800069. PubMed ID: 29635744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing sgRNA position markedly improves the efficiency of CRISPR/dCas9-mediated transcriptional repression.
    Radzisheuskaya A; Shlyueva D; Müller I; Helin K
    Nucleic Acids Res; 2016 Oct; 44(18):e141. PubMed ID: 27353328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward tunable dynamic repression using CRISPRi.
    Jang S; Jang S; Jung GY
    Biotechnol J; 2018 Sep; 13(9):e1800152. PubMed ID: 29714047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of dCas9-mediated CRISPRi in the fission yeast Schizosaccharomyces pombe.
    Ishikawa K; Soejima S; Masuda F; Saitoh S
    G3 (Bethesda); 2021 Apr; 11(4):. PubMed ID: 33617628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered dCas9 with reduced toxicity in bacteria: implications for genetic circuit design.
    Zhang S; Voigt CA
    Nucleic Acids Res; 2018 Nov; 46(20):11115-11125. PubMed ID: 30289463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels.
    Depardieu F; Bikard D
    Methods; 2020 Feb; 172():61-75. PubMed ID: 31377338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Mediated Transcriptional Repression in Toxoplasma gondii.
    Markus BM; Boydston EA; Lourido S
    mSphere; 2021 Oct; 6(5):e0047421. PubMed ID: 34643425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of CRISPR interference in Methylorubrum extorquens and application of rapidly mining a new phytoene desaturase involved in carotenoid biosynthesis.
    Mo XH; Zhang H; Wang TM; Zhang C; Zhang C; Xing XH; Yang S
    Appl Microbiol Biotechnol; 2020 May; 104(10):4515-4532. PubMed ID: 32215707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR Interference Modules as Low-Burden Logic Inverters in Synthetic Circuits.
    Bellato M; Frusteri Chiacchiera A; Salibi E; Casanova M; De Marchi D; Castagliuolo I; Cusella De Angelis MG; Magni P; Pasotti L
    Front Bioeng Biotechnol; 2021; 9():743950. PubMed ID: 35155399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming Leak Sensitivity in CRISPRi Circuits Using Antisense RNA Sequestration and Regulatory Feedback.
    Specht DA; Cortes LB; Lambert G
    ACS Synth Biol; 2022 Sep; 11(9):2927-2937. PubMed ID: 36017994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.
    Rahman MM; Tollefsbol TO
    Methods; 2021 Mar; 187():77-91. PubMed ID: 32315755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional Knockdown in Pneumococci Using CRISPR Interference.
    Kjos M
    Methods Mol Biol; 2019; 1968():89-98. PubMed ID: 30929208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.
    Replogle JM; Bonnar JL; Pogson AN; Liem CR; Maier NK; Ding Y; Russell BJ; Wang X; Leng K; Guna A; Norman TM; Pak RA; Ramos DM; Ward ME; Gilbert LA; Kampmann M; Weissman JS; Jost M
    Elife; 2022 Dec; 11():. PubMed ID: 36576240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Transcriptional Activation in Plants Using a Potent Dead Cas9-Derived Synthetic Gene Activator.
    Li Z; Wang F; Li JF
    Curr Protoc Mol Biol; 2019 Jun; 127(1):e89. PubMed ID: 31237422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR/dCas9-Mediated Multiplex Gene Repression in Streptomyces.
    Zhao Y; Li L; Zheng G; Jiang W; Deng Z; Wang Z; Lu Y
    Biotechnol J; 2018 Sep; 13(9):e1800121. PubMed ID: 29862648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. sgRNA Sequence Motifs Blocking Efficient CRISPR/Cas9-Mediated Gene Editing.
    Graf R; Li X; Chu VT; Rajewsky K
    Cell Rep; 2019 Jan; 26(5):1098-1103.e3. PubMed ID: 30699341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CRISPR Interference Platform for Efficient Genetic Repression in
    Wensing L; Sharma J; Uthayakumar D; Proteau Y; Chavez A; Shapiro RS
    mSphere; 2019 Feb; 4(1):. PubMed ID: 30760609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of a Synthetic Amino Acid into dCas9 Improves Control of Gene Silencing.
    Koopal B; Kruis AJ; Claassens NJ; Nobrega FL; van der Oost J
    ACS Synth Biol; 2019 Feb; 8(2):216-222. PubMed ID: 30668910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.